Radcliffe Capital Management, L.P. - SAB BIOTHERAPEUTICS INC ownership

Back to all holdings Add to watchlist

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 17 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$27,000
-66.7%
38,927
-30.1%
0.00%
-50.0%
Q2 2022$81,000
-85.6%
55,6920.0%0.00%
-84.6%
Q1 2022$562,000
-11.1%
55,692
-31.2%
0.01%
-23.5%
Q4 2021$632,000–80,897–0.02%–
 Download
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
LMR Partners LLP 539,588$318,3030.01%
Shaolin Capital Management LLC 498,109$230.00%
EQUITEC PROPRIETARY MARKETS, LLC 45,000$2,1150.00%
Yakira Capital Management, Inc. 108,485$5,0990.00%
WOLVERINE ASSET MANAGEMENT LLC 12,790$6010.00%
MORGAN STANLEY 148,939$7,0010.00%
Walleye Trading LLC 15,505$7290.00%
FLOW TRADERS U.S. LLC 16,013$10.00%
Walleye Capital LLC 23,258$1,0930.00%
Tower Research Capital LLC (TRC) 48$00.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders